MNPR compared with ADAG: revenue, margins and what each company keeps, and the suppliers and customers both name

MNPRMonopar Therapeutics

Mkt capRevenueRevenue

ADAGAdagene Inc.

Mkt capRevenueRevenue

Compare

MNPRMonopar Therapeutics

ADAGAdagene Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

MNPRMonopar Therapeutics

66.46▼−5.49%· post 66.45

Mkt cap$472.0M

ADAGAdagene Inc.

2.25▼−10.45%· post 2.25

ClosedNov 2 '26

Mkt cap$118.9M

Compare

ClosedNov 2 '26

MNPRMonopar Therapeutics

ADAGAdagene Inc.

66.46▼−5.49%post 66.45

Price

2.25▼−10.45%post 2.25

$472.0M

Mkt cap

$118.9M

MNPR66.46▼−5.49%vsADAG2.25▼−10.45%ClosedNov 2 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

MNPR: latest quarter not drawable. ADAG: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only MNPR 2

AZNAstraZenecasupplier

—NorthStarunlistedsupplier

Shared 0

No shared counterparties.

Only ADAG 7

MRKMercksupplier

EXELExelixiscustomer

SNYSanoficustomer

—Rocheunlisted

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

supplier

3 more · ADAG chain ›

Price

rebased to 0%

MNPR, solidADAG, dashed